Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) had its target price increased by investment analysts at UBS Group from $39.00 to $42.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. UBS Group‘s target price indicates a potential upside of 14.16% from the company’s previous close.
Other research analysts also recently issued reports about the stock. HSBC raised shares of Keurig Dr Pepper from a “hold” rating to a “buy” rating and increased their target price for the company from $37.00 to $40.00 in a research report on Thursday, August 13th. Piper Sandler restated an “overweight” rating on shares of Keurig Dr Pepper in a research note on Wednesday, October 14th. Wells Fargo & Company raised their price objective on Keurig Dr Pepper from $37.00 to $40.00 and gave the stock an “overweight” rating in a report on Wednesday. Bank of America lifted their target price on Keurig Dr Pepper from $35.00 to $38.00 in a research report on Friday, July 10th. Finally, BNP Paribas Exane boosted their target price on Keurig Dr Pepper from $28.00 to $29.00 and gave the company a “neutral” rating in a report on Monday, August 10th. Ten analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus target price of $37.12.
Read Our Latest Stock Analysis on KDP
Keurig Dr Pepper Stock Up 5.9%
KDP stock traded up $2.05 during trading on Wednesday, hitting $36.79. 28,586,576 shares of the company’s stock were exchanged, compared to its average volume of 12,304,528. The business has a 50-day moving average price of $32.58 and a two-hundred day moving average price of $30.07. The company has a current ratio of 0.48, a quick ratio of 0.28 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $50.06 billion, a price-to-earnings ratio of 37.16, a PEG ratio of 1.75 and a beta of 0.35. Keurig Dr Pepper has a 52-week low of $24.88 and a 52-week high of $37.31.
Keurig Dr Pepper (NASDAQ:KDP – Get Free Report) last released its quarterly earnings data on Tuesday, November 3rd. The company reported $0.66 earnings per share for the quarter, topping analysts’ consensus estimates of $0.62 by $0.04. The company had revenue of $7.34 billion for the quarter, compared to analysts’ expectations of $7.33 billion. Keurig Dr Pepper had a net margin of 7.10% and a return on equity of 10.80%. The firm’s revenue for the quarter was up 70.6% on a year-over-year basis. During the same quarter last year, the company earned $0.54 earnings per share. As a group, equities research analysts expect that Keurig Dr Pepper will post 2.30 EPS for the current year.
Insider Buying and Selling
In other news, insider Mary Beth Denooyer sold 12,000 shares of the company’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $32.55, for a total transaction of $390,600.00. Following the transaction, the insider directly owned 84,171 shares of the company’s stock, valued at $2,739,766.05. This represents a 12.48% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Aaron E. Alt purchased 7,862 shares of the business’s stock in a transaction dated Tuesday, August 25th. The stock was bought at an average price of $31.83 per share, with a total value of $250,247.46. Following the acquisition, the director directly owned 7,862 shares in the company, valued at approximately $250,247.46. This represents a ∞ increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. 0.34% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently added to or reduced their stakes in the stock. BlackRock Inc. purchased a new position in shares of Keurig Dr Pepper during the 2nd quarter worth about $4,697,645,000. Barrow Hanley Mewhinney & Strauss LLC acquired a new stake in shares of Keurig Dr Pepper in the second quarter worth approximately $767,105,000. Bank of America Corp DE acquired a new stake in shares of Keurig Dr Pepper in the second quarter worth approximately $281,503,000. Legal & General Group Plc purchased a new stake in Keurig Dr Pepper in the second quarter valued at approximately $269,336,000. Finally, Bank of New York Mellon Corp purchased a new stake in Keurig Dr Pepper in the second quarter valued at approximately $231,345,000. 93.99% of the stock is currently owned by institutional investors and hedge funds.
Key Keurig Dr Pepper News
Here are the key news stories impacting Keurig Dr Pepper this week:
- Positive Sentiment: KDP reported third-quarter adjusted EPS of $0.66, above analyst expectations, while revenue of $7.34 billion edged past estimates. Earnings grew from $0.54 a year earlier, supported by beverage growth and the JDE Peet’s acquisition. The company reaffirmed its 2026 outlook. Keurig Dr Pepper Q3 results
- Positive Sentiment: JPMorgan raised its price target to $41 and maintained an Overweight rating. Morgan Stanley also raised its target, to $40, and kept an Overweight rating; Piper Sandler lifted its target to $41. These moves indicate continued analyst optimism. JPMorgan price-target update Piper Sandler price-target update
- Positive Sentiment: The company’s energy-drink market share topped 10% following recent brand acquisitions, offering another potential growth engine alongside its established beverage businesses. Long-term investor takeaways
- Neutral Sentiment: TD Cowen raised its price target to $35 but retained a Hold rating, signaling a more cautious view than the Overweight calls. TD Cowen price-target update
- Negative Sentiment: KDP warned that U.S. coffee profitability may slow in the fourth quarter as consumers trade down, a near-term headwind that tempers the strong headline results. Report on fourth-quarter coffee profits
Keurig Dr Pepper Company Profile
Keurig Dr Pepper Inc (NASDAQ: KDP) is a beverage company that operates across coffee and packaged beverages. Its portfolio includes soft drinks, flavored waters, juices, juice drinks, ready-to-drink teas and coffees, sports and energy beverages, and mixers, as well as single-serve coffee brewing systems and pods.
The company’s brands include Keurig, Green Mountain Coffee Roasters, The Original Donut Shop, Dr Pepper, Canada Dry, Snapple, 7UP, A&W, Mott’s, Bai, CORE Hydration and Venom, among others.
Featured Articles
- Five stocks we like better than Keurig Dr Pepper
- Why ExxonMobil and Chevron Reminded Investors to Keep it Simple
- Amazon Has Erased Its Earnings Sell-Off, But Is the Biggest Opportunity Still Ahead?
- onsemi’s AI Sales Surge 175%: Is a Stock Recovery Next?
- Energy Transfer’s Earnings Miss May Be Hiding Its Strongest Advantage
Receive News & Ratings for Keurig Dr Pepper Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Keurig Dr Pepper and related companies with MarketBeat.com's FREE daily email newsletter.
